JC
AERI

Jetstream Capital’s Aerie Pharmaceuticals AERI Stock Holding History

Jetstream Capital’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-90,000
Closed -$1.86M – 50
2014
Q3 		$1.86M Buy
90,000
+50,000
+125% +$986K 0.03% 23
2014
Q2 		$991K Buy
+40,000
New +$693K 0.03% 35

Other funds holding AERI

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Jetstream Capital's AERI Position: Q4 2014 in Review

Jetstream Capital sold out of Aerie Pharmaceuticals (AERI) in Q4 2014, closing a stake of 90,000 shares — an estimated $1.86M sold.

Jetstream Capital first reported a position in AERI in Q2 2014 and held it in 2 quarters. The position peaked at $1.86M in Q3 2014. 98 funds tracked by Wall St. Rank hold AERI as of Q4 2014.

  • Jetstream Capital reported no remaining Aerie Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Jetstream Capital sold 90,000 Aerie Pharmaceuticals shares in Q4 2014, an estimated $1.86M.
  • Jetstream Capital first reported a position in Aerie Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • Jetstream Capital's Aerie Pharmaceuticals position peaked at $1.86M in Q3 2014.
  • 98 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2014.

Based on Jetstream Capital's 13F filing for Q4 2014, filed 17 Feb 2015.